This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
4D Molecular Therapeutics (FDMT) delivered earnings and revenue surprises of -11.36% and -98.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FDMTPositive Net Change SPRYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FGENPositive Net Change AIMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FGI Industries Ltd. (FGI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
FGI Industries (FGI) delivered earnings and revenue surprises of -100.00% and -4.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FGINegative Net Change HDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fluence Energy, Inc. (FLNC) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Fluence Energy (FLNC) delivered earnings and revenue surprises of +150.00% and -19.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FLNCNegative Net Change NOVAQNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
L.B. Foster (FSTR) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
L.B. Foster (FSTR) delivered earnings and revenue surprises of -48.08% and -0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FSTRNegative Net Change HYFMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
3D Systems (DDD) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
3D Systems (DDD) delivered earnings and revenue surprises of +46.15% and -3.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DDDNo Net Change SSYSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dun & Bradstreet (DNB) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Dun & Bradstreet (DNB) delivered earnings and revenue surprises of -20.83% and -1.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DNBNo Net Change UCLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Draganfly Inc. (DPRO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Draganfly (DPRO) delivered earnings and revenue surprises of +4.35% and +24.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DPROPositive Net Change AINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Viant Technology (DSP) Q2 Earnings Miss Estimates
by Zacks Equity Research
Viant (DSP) delivered earnings and revenue surprises of -10.00% and +0.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DSPNegative Net Change KSCPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
EuroDry (EDRY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
EuroDry (EDRY) delivered earnings and revenue surprises of +10.57% and -1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EDRYNegative Net Change FLNGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of +32.00% and +21.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ENTAPositive Net Change FATENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ballard Power Systems (BLDP) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ballard (BLDP) delivered earnings and revenue surprises of +20.00% and -6.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BLDPNegative Net Change YORWNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Celanese (CE) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of +4.35% and +1.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CEPositive Net Change DQPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Compass Minerals (CMP) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Compass (CMP) delivered earnings and revenue surprises of -200.00% and +2.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CMPNegative Net Change ASMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dana (DAN) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Dana (DAN) delivered earnings and revenue surprises of -87.50% and -11.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DANNegative Net Change WKHSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aris Water Solutions, Inc. (ARIS) Misses Q2 Earnings Estimates
by Zacks Equity Research
Aris Water Solutions (ARIS) delivered earnings and revenue surprises of -20.83% and +3.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ARISNegative Net Change SHIMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arq, Inc. (ARQ) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arq, Inc. (ARQ) delivered earnings and revenue surprises of 0.00% and +10.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ARQNegative Net Change BBCPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Assertio (ASRT) delivered earnings and revenue surprises of -70.00% and +4.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ASRTNegative Net Change NTRBNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AST SpaceMobile, Inc. (ASTS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
AST SpaceMobile (ASTS) delivered earnings and revenue surprises of -115.79% and -77.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ASTSPositive Net Change UIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BigBear.ai Holdings, Inc. (BBAI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
BigBear.ai (BBAI) delivered earnings and revenue surprises of +14.29% and -20.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BBAIPositive Net Change EVLVPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -36.36% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BHSTPositive Net Change GRALPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ACV Auctions Inc. (ACVA) Matches Q2 Earnings Estimates
by Zacks Equity Research
ACV Auctions (ACVA) delivered earnings and revenue surprises of 0.00% and -1.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACVANegative Net Change CPRTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Agenus (AGEN) delivered earnings and revenue surprises of -28.21% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AGENNegative Net Change INONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AQSTPositive Net Change VYNENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +69.37% and +20.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ARCTPositive Net Change IMTXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank